In one study, patients with GBM harboring isocitrate dehydrogenase I (IDH1) gene mutations exhibited higher survival rates than patients with GBM harboring the wild-type gene, because glioma cells harboring the mutation exhibit lower enzymatic activity than those with the wild-type gene [8]. The gene discussed is IDH1; the disease is glioblastoma.